Five Prime Therapeutics, Inc.
FPRX
FPRX was delisted on the 15th of April, 2021.
4 hedge funds and large institutions have $6.62M invested in Five Prime Therapeutics, Inc. in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AWMDMG
1
Austin W. Marxe & David M. Greenhouse
New York
| $4.58M | +$4.73M | +350,000 | New |
|
2
Alyeska Investment Group
Chicago,
Illinois
| $1.67M | +$1.72M | +127,500 | New |
|
|
WSA
3
Wall Street Associates
Lajolla,
California
| $327K | +$338K | +25,000 | New |
|
|
MCM
4
Mazama Capital Management
Portland,
Oregon
| $40K | +$41.8K | +3,088 | New |
|
FPRX Hedge Fund Activity: Q3 2013 in Review
4 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q3 2013, worth a combined $6.62M.
Buyers outnumbered sellers: 4 funds opened new FPRX positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Austin W. Marxe & David M. Greenhouse, opening a new position worth an estimated $4.73M.
- 4 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q3 2013, up from 0 in Q2 2013.
- Funds reported $6.62M of Five Prime Therapeutics, Inc. stock for Q3 2013.
- 4 funds opened new Five Prime Therapeutics, Inc. positions in Q3 2013 and 0 closed out, a net change of +4 holders.
- The largest Five Prime Therapeutics, Inc. buyer in Q3 2013 was Austin W. Marxe & David M. Greenhouse, an estimated $4.73M added.
Based on aggregated 13F filings for Q3 2013.